Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsCisplatinChemotherapy, AdjuvantDoxorubicinCyclophosphamideCombined Modality TherapyEtoposideTreatment OutcomeBleomycinVinblastineVincristineDrug Administration SchedulePaclitaxelMethotrexateLung NeoplasmsSurvival AnalysisCarboplatinRadiation DosageDisease-Free SurvivalRadiation, IonizingBreast NeoplasmsDeoxycytidineNeoplasmsOrganoplatinum CompoundsSurvival RateNeoplasm StagingAntineoplastic Agents, PhytogenicPrognosisDrug Resistance, NeoplasmRadiation InjuriesIfosfamideCamptothecinTaxoidsCell Line, TumorProcarbazineNeoadjuvant TherapyFluorouracilLeukopeniaTesticular NeoplasmsNeoplasm Recurrence, LocalAntimetabolites, AntineoplasticDrug Screening Assays, AntitumorAntibiotics, AntineoplasticCytarabineDose-Response Relationship, RadiationMechlorethamineNeoplasm MetastasisPrednisoneOvarian NeoplasmsHodgkin DiseaseTegafurClinical Trials as TopicLymphoma, Non-HodgkinRadiation ToleranceAntineoplastic Agents, AlkylatingSalvage TherapyCarmustineAdenocarcinomaCarcinoma, Non-Small-Cell LungMitomycinNeoplasms, Germ Cell and EmbryonalFollow-Up StudiesActuarial AnalysisRadiotherapyTime FactorsDose-Response Relationship, DrugLomustineNeutropeniaRadiationDacarbazineAltretamineMitoxantroneStomach NeoplasmsOxonic AcidApoptosisNimustineNauseaInfusions, IntravenousLymphomaRadiotherapy DosageMelphalanPlatinumDaunorubicinMitomycinsRadiation ProtectionCarcinoma, Small CellPrednisoloneAnthracyclinesRadiotherapy, AdjuvantRadiation MonitoringDrug EvaluationThrombocytopeniaCarcinomaColorectal NeoplasmsCell SurvivalInduction ChemotherapyLiver NeoplasmsVomitingBrain Neoplasms